PUBLISHER: QYResearch | PRODUCT CODE: 1873626
PUBLISHER: QYResearch | PRODUCT CODE: 1873626
Calculus Bovis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Calculus Bovis was estimated to be worth US$ 175 million in 2024 and is forecast to a readjusted size of US$ 504 million by 2031 with a CAGR of 15.8% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Calculus Bovis cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Bezoar is a bovine gallstone used in traditional Chinese medicine. In countries such as China and Japan, it has long been used to treat a variety of diseases, including high fever, convulsions and stroke. In Asian countries, cattle stones are sometimes harvested when cattle are slaughtered. Bezoar is a dried gallstone of cattle, a mammal of the phylum Chordata. Those produced in the gallbladder are called "bile yellow" or "egg yolk", those produced in the bile duct are called "tube yellow", and those produced in the hepatic duct are called "liver yellow". The complete bezoar is mostly oval in shape, light in texture, with a golden to yellow-brown surface, delicate and shiny. Traditional Chinese medicine believes that bezoar has a fresh fragrance, a slightly bitter taste and then sweet, and a cool nature. It can be used to relieve fever, detoxify, and calm the nerves. It can be taken internally to treat high fever, coma, mania, infantile convulsions, convulsions, etc. It can be used externally to treat sore throat, mouth sores, carbuncle, and toxicity.
Because natural bezoar is extremely rare and cannot be produced industrially. Therefore, this report mainly counts two types of products: in vitro cultivated bezoar and artificial bezoar.
The global key manufacturers of calculus bovis include Jianmin Group, Dibo Pharmaceuticals, Mingxing Pharmaceuticals, Renqi Pharmaceuticals, Hongmao Pharmaceuticals, and Tongrentang. The top five manufacturers together account for 80% of the market share, with Jianmin Group being the largest producer with 20% of the market share. The global origin is mainly concentrated in China. At the consumer level, China holds close to 90% of the market share. In terms of product category, it is divided into in vitro calculus bovis and artificial bezoar, with the former having a higher market share of 75%. In terms of its application,preparations medicine is its top application area with 95% market share, followed by Chinese hebal medicine.
The driving factors of the bezoar market mainly include
1. Resource scarcity: rigid constraints on the supply of natural bezoar
Production bottleneck
Cause: Bezoar is a pathological product. Only 0.1%-0.2% of cattle gallstones can form natural bezoar, and the breeding cycle is long (requires 3-5 years).
2. Policy control: industry access and standard upgrade
Production license control
China only allows 6 companies (such as Jianmin Group and Tongrentang) to produce natural bezoar, and implements a quota system with an annual quota of less than 800 kilograms.
The 2025 edition of the "Chinese Pharmacopoeia" raises the detection standard for bezoar content, and the impurity limit is tightened from 2% to 0.5%, forcing companies to optimize procurement and processing technology.
3. Consumption upgrade: Demand for high-end Chinese medicine explodes
Chinese patent medicine field
Angong Niuhuang Wan: The core raw material bezoar accounts for 10%, and the annual demand exceeds 200 tons, driving the use of bezoar to increase by 15%.
Pianzaihuang: The unit price of natural bezoar formula products exceeds 1,000 yuan/tablet, and sales increase by 20% year-on-year.
Health products and cosmeceuticals extension
Bezoar toothpaste: adding trace amounts of bezoar ingredients, the unit price is 5 times that of ordinary toothpaste, and the market share increases by 25% annually.
Anti-aging products: bezoar extract is used for high-end skin care, and the target customer group CAGR reaches 30%.
4. Technology substitution: breakthrough in in vitro cultivation of bezoar
Industrialization process is accelerated
Wuhan Jianmin Dapeng Pharmaceutical has achieved large-scale production of in vitro cultivated bezoar, with a cost of only 1/10 of natural bezoar and an annual production capacity of 5 tons.
Efficacy verification: The State Food and Drug Administration has approved it to replace natural bezoar for 42 kinds of Chinese patent medicines, covering 80% of bezoar preparations.
Market penetration rate increases
In vitro cultivated bezoar has a market share of more than 60% in the low- and medium-end markets, squeezing out the demand for natural bezoar, but it is still irreplaceable in the high-end field.
5. Capital drive: industrial chain integration and financialization
Upstream resource monopoly
Pianzihuang and Tongrentang lock in cattle sources by holding overseas ranches.
Futures and financial derivatives
Bezoar futures are listed on the Bozhou Chinese Medicine Exchange, with an annual trading volume of over 5 billion yuan. The price discovery function reduces corporate procurement risks.
6. Cultural beliefs: Traditional medical cognition is solidified
The status of the pharmacopoeia is unshakable
The "Shennong Bencao Jing" lists bezoar as a top-grade product, and its status as the first of the "three treasures of cold water" in traditional Chinese medicine theory deepens consumer cognition.
Gift attributes are strengthened
Natural bezoar products have become high-end gifts, and the annual sales of bezoar handicrafts with a unit price of more than 100,000 yuan exceeds 1 billion yuan.
7. Challenges and coping strategies
Sustainable supply problems
Countermeasures: Promote in vitro cultivation technology, develop synthetic biology pathways for bezoar, and reduce dependence on natural resources.
Price volatility risk
Countermeasures: Establish a national strategic reserve system, improve hedging tools in the futures market, and smooth the cost curve of enterprises.
The bezoar market is a typical scenario of resource scarcity, policy control, consumption upgrades and technological substitution resonance. In the future, the industry will present the triple trends of "high-end natural bezoar, large-scale in vitro cultivation, and financialization of the industrial chain." Enterprises need to seek a balance between supply constraints and demand explosion through technological breakthroughs, resource monopoly and cultural marketing, and dominate the market structure in the next decade.
This report aims to provide a comprehensive presentation of the global market for Calculus Bovis, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Calculus Bovis by region & country, by Type, and by Application.
The Calculus Bovis market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calculus Bovis.
Market Segmentation
By Company
- Jianmin Group
- Dibo Pharmaceuticals
- Ming Hing Pharmaceutical
- Renqi Pharmaceutical
- Hongmao Pharmaceutical
- Tongrentang
Segment by Type
- Artificial Bezoar
- In Vitro Cultured Bezoar
Segment by Application
- Preparations Medicine
- Chinese Herbal Medicine
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Calculus Bovis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Calculus Bovis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Calculus Bovis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Calculus Bovis Product Introduction
- 1.2 Global Calculus Bovis Market Size Forecast
- 1.2.1 Global Calculus Bovis Sales Value (2020-2031)
- 1.2.2 Global Calculus Bovis Sales Volume (2020-2031)
- 1.2.3 Global Calculus Bovis Sales Price (2020-2031)
- 1.3 Calculus Bovis Market Trends & Drivers
- 1.3.1 Calculus Bovis Industry Trends
- 1.3.2 Calculus Bovis Market Drivers & Opportunity
- 1.3.3 Calculus Bovis Market Challenges
- 1.3.4 Calculus Bovis Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Calculus Bovis Players Revenue Ranking (2024)
- 2.2 Global Calculus Bovis Revenue by Company (2020-2025)
- 2.3 Global Calculus Bovis Players Sales Volume Ranking (2024)
- 2.4 Global Calculus Bovis Sales Volume by Company Players (2020-2025)
- 2.5 Global Calculus Bovis Average Price by Company (2020-2025)
- 2.6 Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
- 2.7 Key Manufacturers Calculus Bovis Product Offered
- 2.8 Key Manufacturers Time to Begin Mass Production of Calculus Bovis
- 2.9 Calculus Bovis Market Competitive Analysis
- 2.9.1 Calculus Bovis Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Calculus Bovis Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
- 2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 Artificial Bezoar
- 3.1.2 In Vitro Cultured Bezoar
- 3.2 Global Calculus Bovis Sales Value by Type
- 3.2.1 Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Calculus Bovis Sales Value, by Type (2020-2031)
- 3.2.3 Global Calculus Bovis Sales Value, by Type (%) (2020-2031)
- 3.3 Global Calculus Bovis Sales Volume by Type
- 3.3.1 Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Calculus Bovis Sales Volume, by Type (2020-2031)
- 3.3.3 Global Calculus Bovis Sales Volume, by Type (%) (2020-2031)
- 3.4 Global Calculus Bovis Average Price by Type (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Preparations Medicine
- 4.1.2 Chinese Herbal Medicine
- 4.2 Global Calculus Bovis Sales Value by Application
- 4.2.1 Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Calculus Bovis Sales Value, by Application (2020-2031)
- 4.2.3 Global Calculus Bovis Sales Value, by Application (%) (2020-2031)
- 4.3 Global Calculus Bovis Sales Volume by Application
- 4.3.1 Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Calculus Bovis Sales Volume, by Application (2020-2031)
- 4.3.3 Global Calculus Bovis Sales Volume, by Application (%) (2020-2031)
- 4.4 Global Calculus Bovis Average Price by Application (2020-2031)
5 Segmentation by Region
- 5.1 Global Calculus Bovis Sales Value by Region
- 5.1.1 Global Calculus Bovis Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Calculus Bovis Sales Value by Region (2020-2025)
- 5.1.3 Global Calculus Bovis Sales Value by Region (2026-2031)
- 5.1.4 Global Calculus Bovis Sales Value by Region (%), (2020-2031)
- 5.2 Global Calculus Bovis Sales Volume by Region
- 5.2.1 Global Calculus Bovis Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Calculus Bovis Sales Volume by Region (2020-2025)
- 5.2.3 Global Calculus Bovis Sales Volume by Region (2026-2031)
- 5.2.4 Global Calculus Bovis Sales Volume by Region (%), (2020-2031)
- 5.3 Global Calculus Bovis Average Price by Region (2020-2031)
- 5.4 North America
- 5.4.1 North America Calculus Bovis Sales Value, 2020-2031
- 5.4.2 North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- 5.5 Europe
- 5.5.1 Europe Calculus Bovis Sales Value, 2020-2031
- 5.5.2 Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- 5.6 Asia Pacific
- 5.6.1 Asia Pacific Calculus Bovis Sales Value, 2020-2031
- 5.6.2 Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
- 5.7 South America
- 5.7.1 South America Calculus Bovis Sales Value, 2020-2031
- 5.7.2 South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- 5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Calculus Bovis Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Calculus Bovis Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Calculus Bovis Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Calculus Bovis Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Calculus Bovis Sales Volume, 2020-2031
- 6.3 United States
- 6.3.1 United States Calculus Bovis Sales Value, 2020-2031
- 6.3.2 United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Calculus Bovis Sales Value, 2020-2031
- 6.4.2 Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Calculus Bovis Sales Value, 2020-2031
- 6.5.2 China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Calculus Bovis Sales Value, 2020-2031
- 6.6.2 Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Calculus Bovis Sales Value, 2020-2031
- 6.7.2 South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Calculus Bovis Sales Value, 2020-2031
- 6.8.2 Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Calculus Bovis Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Calculus Bovis Sales Value, 2020-2031
- 6.9.2 India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Calculus Bovis Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Jianmin Group
- 7.1.1 Jianmin Group Company Information
- 7.1.2 Jianmin Group Introduction and Business Overview
- 7.1.3 Jianmin Group Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Jianmin Group Calculus Bovis Product Offerings
- 7.1.5 Jianmin Group Recent Development
- 7.2 Dibo Pharmaceuticals
- 7.2.1 Dibo Pharmaceuticals Company Information
- 7.2.2 Dibo Pharmaceuticals Introduction and Business Overview
- 7.2.3 Dibo Pharmaceuticals Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Dibo Pharmaceuticals Calculus Bovis Product Offerings
- 7.2.5 Dibo Pharmaceuticals Recent Development
- 7.3 Ming Hing Pharmaceutical
- 7.3.1 Ming Hing Pharmaceutical Company Information
- 7.3.2 Ming Hing Pharmaceutical Introduction and Business Overview
- 7.3.3 Ming Hing Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Ming Hing Pharmaceutical Calculus Bovis Product Offerings
- 7.3.5 Ming Hing Pharmaceutical Recent Development
- 7.4 Renqi Pharmaceutical
- 7.4.1 Renqi Pharmaceutical Company Information
- 7.4.2 Renqi Pharmaceutical Introduction and Business Overview
- 7.4.3 Renqi Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Renqi Pharmaceutical Calculus Bovis Product Offerings
- 7.4.5 Renqi Pharmaceutical Recent Development
- 7.5 Hongmao Pharmaceutical
- 7.5.1 Hongmao Pharmaceutical Company Information
- 7.5.2 Hongmao Pharmaceutical Introduction and Business Overview
- 7.5.3 Hongmao Pharmaceutical Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Hongmao Pharmaceutical Calculus Bovis Product Offerings
- 7.5.5 Hongmao Pharmaceutical Recent Development
- 7.6 Tongrentang
- 7.6.1 Tongrentang Company Information
- 7.6.2 Tongrentang Introduction and Business Overview
- 7.6.3 Tongrentang Calculus Bovis Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Tongrentang Calculus Bovis Product Offerings
- 7.6.5 Tongrentang Recent Development
8 Industry Chain Analysis
- 8.1 Calculus Bovis Industrial Chain
- 8.2 Calculus Bovis Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Calculus Bovis Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Calculus Bovis Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Calculus Bovis Market Trends
- Table 2. Calculus Bovis Market Drivers & Opportunity
- Table 3. Calculus Bovis Market Challenges
- Table 4. Calculus Bovis Market Restraints
- Table 5. Global Calculus Bovis Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Calculus Bovis Revenue Market Share by Company (2020-2025)
- Table 7. Global Calculus Bovis Sales Volume by Company (2020-2025) & (kg)
- Table 8. Global Calculus Bovis Sales Volume Market Share by Company (2020-2025)
- Table 9. Global Market Calculus Bovis Price by Company (2020-2025) & (US$/kg)
- Table 10. Key Manufacturers Calculus Bovis Manufacturing Base and Headquarters
- Table 11. Key Manufacturers Calculus Bovis Product Type
- Table 12. Key Manufacturers Time to Begin Mass Production of Calculus Bovis
- Table 13. Global Calculus Bovis Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calculus Bovis as of 2024)
- Table 15. Mergers & Acquisitions, Expansion Plans
- Table 16. Global Calculus Bovis Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 17. Global Calculus Bovis Sales Value by Type (2020-2025) & (US$ Million)
- Table 18. Global Calculus Bovis Sales Value by Type (2026-2031) & (US$ Million)
- Table 19. Global Calculus Bovis Sales Market Share in Value by Type (2020-2025)
- Table 20. Global Calculus Bovis Sales Market Share in Value by Type (2026-2031)
- Table 21. Global Calculus Bovis Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
- Table 22. Global Calculus Bovis Sales Volume by Type (2020-2025) & (kg)
- Table 23. Global Calculus Bovis Sales Volume by Type (2026-2031) & (kg)
- Table 24. Global Calculus Bovis Sales Market Share in Volume by Type (2020-2025)
- Table 25. Global Calculus Bovis Sales Market Share in Volume by Type (2026-2031)
- Table 26. Global Calculus Bovis Price by Type (2020-2025) & (US$/kg)
- Table 27. Global Calculus Bovis Price by Type (2026-2031) & (US$/kg)
- Table 28. Global Calculus Bovis Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 29. Global Calculus Bovis Sales Value by Application (2020-2025) & (US$ Million)
- Table 30. Global Calculus Bovis Sales Value by Application (2026-2031) & (US$ Million)
- Table 31. Global Calculus Bovis Sales Market Share in Value by Application (2020-2025)
- Table 32. Global Calculus Bovis Sales Market Share in Value by Application (2026-2031)
- Table 33. Global Calculus Bovis Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
- Table 34. Global Calculus Bovis Sales Volume by Application (2020-2025) & (kg)
- Table 35. Global Calculus Bovis Sales Volume by Application (2026-2031) & (kg)
- Table 36. Global Calculus Bovis Sales Market Share in Volume by Application (2020-2025)
- Table 37. Global Calculus Bovis Sales Market Share in Volume by Application (2026-2031)
- Table 38. Global Calculus Bovis Price by Application (2020-2025) & (US$/kg)
- Table 39. Global Calculus Bovis Price by Application (2026-2031) & (US$/kg)
- Table 40. Global Calculus Bovis Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 41. Global Calculus Bovis Sales Value by Region (2020-2025) & (US$ Million)
- Table 42. Global Calculus Bovis Sales Value by Region (2026-2031) & (US$ Million)
- Table 43. Global Calculus Bovis Sales Value by Region (2020-2025) & (%)
- Table 44. Global Calculus Bovis Sales Value by Region (2026-2031) & (%)
- Table 45. Global Calculus Bovis Sales Volume by Region (kg): 2020 VS 2024 VS 2031
- Table 46. Global Calculus Bovis Sales Volume by Region (2020-2025) & (kg)
- Table 47. Global Calculus Bovis Sales Volume by Region (2026-2031) & (kg)
- Table 48. Global Calculus Bovis Sales Volume by Region (2020-2025) & (%)
- Table 49. Global Calculus Bovis Sales Volume by Region (2026-2031) & (%)
- Table 50. Global Calculus Bovis Average Price by Region (2020-2025) & (US$/kg)
- Table 51. Global Calculus Bovis Average Price by Region (2026-2031) & (US$/kg)
- Table 52. Key Countries/Regions Calculus Bovis Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 53. Key Countries/Regions Calculus Bovis Sales Value, (2020-2025) & (US$ Million)
- Table 54. Key Countries/Regions Calculus Bovis Sales Value, (2026-2031) & (US$ Million)
- Table 55. Key Countries/Regions Calculus Bovis Sales Volume, (2020-2025) & (kg)
- Table 56. Key Countries/Regions Calculus Bovis Sales Volume, (2026-2031) & (kg)
- Table 57. Jianmin Group Company Information
- Table 58. Jianmin Group Introduction and Business Overview
- Table 59. Jianmin Group Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 60. Jianmin Group Calculus Bovis Product Offerings
- Table 61. Jianmin Group Recent Development
- Table 62. Dibo Pharmaceuticals Company Information
- Table 63. Dibo Pharmaceuticals Introduction and Business Overview
- Table 64. Dibo Pharmaceuticals Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 65. Dibo Pharmaceuticals Calculus Bovis Product Offerings
- Table 66. Dibo Pharmaceuticals Recent Development
- Table 67. Ming Hing Pharmaceutical Company Information
- Table 68. Ming Hing Pharmaceutical Introduction and Business Overview
- Table 69. Ming Hing Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 70. Ming Hing Pharmaceutical Calculus Bovis Product Offerings
- Table 71. Ming Hing Pharmaceutical Recent Development
- Table 72. Renqi Pharmaceutical Company Information
- Table 73. Renqi Pharmaceutical Introduction and Business Overview
- Table 74. Renqi Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 75. Renqi Pharmaceutical Calculus Bovis Product Offerings
- Table 76. Renqi Pharmaceutical Recent Development
- Table 77. Hongmao Pharmaceutical Company Information
- Table 78. Hongmao Pharmaceutical Introduction and Business Overview
- Table 79. Hongmao Pharmaceutical Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 80. Hongmao Pharmaceutical Calculus Bovis Product Offerings
- Table 81. Hongmao Pharmaceutical Recent Development
- Table 82. Tongrentang Company Information
- Table 83. Tongrentang Introduction and Business Overview
- Table 84. Tongrentang Calculus Bovis Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
- Table 85. Tongrentang Calculus Bovis Product Offerings
- Table 86. Tongrentang Recent Development
- Table 87. Key Raw Materials Lists
- Table 88. Raw Materials Key Suppliers Lists
- Table 89. Calculus Bovis Downstream Customers
- Table 90. Calculus Bovis Distributors List
- Table 91. Research Programs/Design for This Report
- Table 92. Key Data Information from Secondary Sources
- Table 93. Key Data Information from Primary Sources
List of Figures
- Figure 1. Calculus Bovis Product Picture
- Figure 2. Global Calculus Bovis Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Calculus Bovis Sales Value (2020-2031) & (US$ Million)
- Figure 4. Global Calculus Bovis Sales Volume (2020-2031) & (kg)
- Figure 5. Global Calculus Bovis Sales Price (2020-2031) & (US$/kg)
- Figure 6. Calculus Bovis Report Years Considered
- Figure 7. Global Calculus Bovis Players Revenue Ranking (2024) & (US$ Million)
- Figure 8. Global Calculus Bovis Players Sales Volume Ranking (2024) & (kg)
- Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Calculus Bovis Revenue in 2024
- Figure 10. Calculus Bovis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 11. Artificial Bezoar Picture
- Figure 12. In Vitro Cultured Bezoar Picture
- Figure 13. Global Calculus Bovis Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 14. Global Calculus Bovis Sales Value Market Share by Type, 2024 & 2031
- Figure 15. Global Calculus Bovis Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
- Figure 16. Global Calculus Bovis Sales Volume Market Share by Type, 2024 & 2031
- Figure 17. Global Calculus Bovis Price by Type (2020-2031) & (US$/kg)
- Figure 18. Product Picture of Preparations Medicine
- Figure 19. Product Picture of Chinese Herbal Medicine
- Figure 20. Global Calculus Bovis Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 21. Global Calculus Bovis Sales Value Market Share by Application, 2024 & 2031
- Figure 22. Global Calculus Bovis Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
- Figure 23. Global Calculus Bovis Sales Volume Market Share by Application, 2024 & 2031
- Figure 24. Global Calculus Bovis Price by Application (2020-2031) & (US$/kg)
- Figure 25. North America Calculus Bovis Sales Value (2020-2031) & (US$ Million)
- Figure 26. North America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- Figure 27. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 28. Europe Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- Figure 29. Asia Pacific Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 30. Asia Pacific Calculus Bovis Sales Value by Region (%), 2024 VS 2031
- Figure 31. South America Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 32. South America Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- Figure 33. Middle East & Africa Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 34. Middle East & Africa Calculus Bovis Sales Value by Country (%), 2024 VS 2031
- Figure 35. Key Countries/Regions Calculus Bovis Sales Value (%), (2020-2031)
- Figure 36. Key Countries/Regions Calculus Bovis Sales Volume (%), (2020-2031)
- Figure 37. United States Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 38. United States Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 39. United States Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 40. Europe Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 41. Europe Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 42. Europe Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 43. China Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 44. China Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 45. China Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 46. Japan Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 47. Japan Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 48. Japan Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 49. South Korea Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 50. South Korea Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 51. South Korea Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 52. Southeast Asia Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 53. Southeast Asia Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 54. Southeast Asia Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 55. India Calculus Bovis Sales Value, (2020-2031) & (US$ Million)
- Figure 56. India Calculus Bovis Sales Value by Type (%), 2024 VS 2031
- Figure 57. India Calculus Bovis Sales Value by Application (%), 2024 VS 2031
- Figure 58. Calculus Bovis Industrial Chain
- Figure 59. Calculus Bovis Manufacturing Cost Structure
- Figure 60. Channels of Distribution (Direct Sales, and Distribution)
- Figure 61. Bottom-up and Top-down Approaches for This Report
- Figure 62. Data Triangulation
- Figure 63. Key Executives Interviewed
